4,813
Views
13
CrossRef citations to date
0
Altmetric
Review

Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review

, , &
Pages 721-731 | Received 12 May 2016, Accepted 09 Jan 2017, Published online: 25 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Khaled Habas, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, Anwarul Azim Majumder & Talat Nasim. (2020) Resolution of coronavirus disease 2019 (COVID-19). Expert Review of Anti-infective Therapy 18:12, pages 1201-1211.
Read now
Heeyoun Cho, Jean-Louis Excler, Jerome H. Kim & In-Kyu Yoon. (2018) Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges. Human Vaccines & Immunotherapeutics 14:2, pages 304-313.
Read now

Articles from other publishers (11)

K. Savina, Rakhy Sreekumar, V. K. Soonu & E. J. Variyar. (2022) Various vaccine platforms in the field of COVID-19. Beni-Suef University Journal of Basic and Applied Sciences 11:1.
Crossref
Abdallah A. Hassanin, Sayed Haidar Abbas Raza, Javed Ahmed Ujjan, Ayshah Aysh ALrashidi, Basel M. Sitohy, Ameena A. AL-surhanee, Ahmed M. Saad, Tahani Mohamed Al -Hazani, Osama Osman Atallah, Khalid M. Al Syaad, Ahmed Ezzat Ahmed, Ayman A. Swelum, Mohamed T. El-Saadony & Mahmoud Z. Sitohy. (2022) Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. Saudi Journal of Biological Sciences 29:4, pages 1981-1997.
Crossref
Sneh Lata, Ritu Mishra, Ravi P. Arya, Pooja Arora, Anismrita Lahon, Akhil C. Banerjea & Vikas Sood. (2022) Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection. Journal of Molecular Biology 434:5, pages 167403.
Crossref
Mohamed Abd Elkodous, Gharieb S. El-Sayyad & Mohamed M. Abdel-Daim. (2020) Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics. Environmental Science and Pollution Research 28:30, pages 40409-40415.
Crossref
Jing Zhao, Shan Zhao, Junxian Ou, Jing Zhang, Wendong Lan, Wenyi Guan, Xiaowei Wu, Yuqian Yan, Wei Zhao, Jianguo Wu, James Chodosh & Qiwei Zhang. (2020) COVID-19: Coronavirus Vaccine Development Updates. Frontiers in Immunology 11.
Crossref
Guilherme Antonio de Souza Silva, Suéllen Pedrosa da Silva, Marcos Aurélio Santos da Costa, Abdênego Rodrigues da Silva, Robson Raion de Vasconcelos Alves, Fernanda das Chagas Ângelo Mendes Tenório, Alanne Rayssa da Silva Melo, Antonio Carlos de Freitas & Cristiane Moutinho Lagos de Melo. (2020) SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development. Journal of Gynecology Obstetrics and Human Reproduction 49:10, pages 101846.
Crossref
Kirtikumar C. Badgujar, Vivek C. Badgujar & Shamkant B. Badgujar. (2020) Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14:5, pages 1361-1376.
Crossref
Simone Carradori. (2020) Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 19:2, pages 85-87.
Crossref
Yan-Hua Li, Chen-Yu Hu, Nan-Ping Wu, Hang-Ping Yao & Lan-Juan Li. (2019) Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins. Engineering 5:5, pages 940-947.
Crossref
Yan-Hua Li, Hainv Gao, Yunfeng Xiao, Tianhao Weng, Dongshan Yu, Chenyu Hu, Hang-Ping Yao & Lan-Juan Li. (2018) Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV. Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV.
Ian Mackay & Katherine Arden. (2017) An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus. Viruses 9:12, pages 369.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.